Tradewinds Universal

What they do

Tradewinds Universal is a holding company whose initial operations were the development and distribution of high-nutrition foods and beverages, including edible insect protein-based bars under the Universal Proteins (UP) brand. It completed development, manufacturing and initial distribution of two bar SKUs, Chocolate Almond and Peanut Butter Fruit, through a partnership with YouBar, Inc. In 2022 it also acquired a canine pain relief formula for development into pet treats, and in 2025 it signed a non-binding LOI with Scar Holdings LLC (Peppermint Hippo) regarding a possible nightlife and hospitality division.

Revenue drivers

• Management fee income — The only revenue source in the quarter ended June 30, 2026; the six-month 2026 total of $46,800 included $25,000 of management fee income.
• Product sales (UP protein bars) — Contributed $15,000 of six-month 2026 revenue; two SKUs were produced via YouBar, Inc., and a 1,040-case distributor order was fully sold by September 30, 2024.
• Distribution income — $6,800 of six-month 2026 revenue; the comparable 2025 periods also included management fee and distribution income.

Recent performance

Second-quarter 2026 revenue was $25,000, up from $20,000 a year earlier, and six-month revenue was $46,800 versus $32,972 in 2025. Gross profit equaled revenue in each period because no cost of sales was reported. Operating expenses jumped to $2,891,860 in the June 2026 quarter from $45,143, and to $3,039,001 for the six months, driven mainly by $2,858,498 of consulting expense plus professional fees, marketing, amortization and G&A. The quarter's net loss was $2,866,860 versus $25,143, and the six-month net loss was $2,992,201 versus $26,255. At June 30, 2026 the company had $8,636 of cash, $276,331 of total assets and $184,331 of shareholder equity.

Strategy

Management says it intends to keep expanding the UP product line, commercialize the canine pain relief formula, and explore licensing and distribution opportunities. It is also evaluating opportunities in the nightlife and hospitality markets under the August 19, 2025 non-binding LOI with Scar Holdings LLC for a possible Peppermint Hippo division, beginning with Peppermint Hippo Toledo in Ohio. Management notes no definitive acquisition agreement has been signed and any deal depends on due diligence, definitive agreements, consents, financing and regulatory approvals. Operating expenses are expected to remain elevated as it develops products, pursues strategic opportunities and remains public. The company states it is working to secure funding through additional equity or debt financing.

Risks

• No profitability or operating cash generation — The company has incurred losses since inception, has not generated positive operating cash flow, and reported net losses of $2,992,201 for the six months ended June 30, 2026.
• Tiny cash balance versus expenses — With only $8,636 of cash and cash equivalents at June 30, 2026 against $2.9 million of quarterly operating expenses, continued operations depend on raising additional financing.
• Uncertain Peppermint Hippo transaction — The nightlife division rests on a non-binding LOI with Scar Holdings LLC and no definitive agreement exists, with completion subject to approvals, financing and licensing.
• OTC market and liquidity — The stock trades on OTCMarkets rather than a national securities exchange, which management cites as a source of limited liquidity and increased volatility.

Outlook

Management expects operating expenses to remain elevated as it develops new product lines, pursues strategic opportunities and operates as a public company, with net losses likely to vary with the timing of marketing, R&D, professional fees and potential acquisitions. It intends to continue expanding UP bars, commercialize the canine pain relief formula and evaluate nightlife and hospitality opportunities. It also states it is seeking additional equity or debt financing to support growth, while warning that larger-scale distribution agreements remain uncertain.